CRSP News and Press, CRISPR Therapeutics AG From 05/02/24

2024-05-02 07:15:00 ET The phrase "the golden age of biotech" was somewhat popular a few years ago but now seems largely forgotten. Regardless, biotech companies can be excellent long-term investment options for several reasons. Many are highly innovative corporations that develop break...

2024-04-30 13:25:04 ET Summary CRISPR/Cas9 technology allows for precise editing of DNA, potentially treating human diseases by replacing entire genes. CRISPR Therapeutics has developed the first FDA-approved ex vivo CRISPR/Cas9 therapy, Casgevy, for sickle cell disease and transf...

2024-04-30 08:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-04-25 09:38:14 ET More on Walgreens 3 Reasons Walgreens Can See Upside (Rating Upgrade) Walgreens: New Management Team And Cost-Plus Model Are Exactly What The Doctor Prescribed Walgreens Post-Earnings: Jury's Still Out, Still A Lot Of Questions Walgreen...

2024-04-24 12:40:09 ET Summary Despite recent FDA approvals for its groundbreaking gene editing technology, CRISPR Therapeutics' stock has experienced a decline in value. The company's pipeline of treatments for various diseases presents a significant opportunity for future growth...

ZUG, Switzerland and BOSTON, April 22, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced an oral presentation highlighting the Company's lipid nanoparticle (LN...

2024-04-20 14:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-04-19 03:54:17 ET Summary ARK Invest's 13F portfolio value decreased by 15% this quarter, with the number of holdings increasing from 223 to 230. The top three holdings in the portfolio are Coinbase Global, Tesla, and Block, making up around 20% of the assets. ARK Invest ...

2024-04-15 16:46:49 ET More on bluebird bio, CRISPR Therapeutics, etc. Vertex Pharmaceuticals: Alpine Accelerates Aspiration To Become Biotech Powerhouse Alpine: Vertex Acquisition Brings About More Than IgA Nephropathy Advancement What Vertex Pharmaceuticals Is Gett...

2024-04-15 02:54:24 ET Summary I created two dummy portfolios for a giant tortoise and a cat to provide context for my articles. The first quarter of the year is ending, prompting a swift evaluation of the evolution, results, metrics, critique style, and unresolved points of these...